Daniela Traini researcher
Traini, Daniela
VIAF ID: 254631645 (Personal)
Permalink: http://viaf.org/viaf/254631645
Preferred Forms
-
100 0 _ ‡a Daniela Traini ‡c researcher
-
100 1 _ ‡a Traini, Daniela
-
100 1 _ ‡a Traini, Daniela
-
100 1 _ ‡a Traini, Daniela
-
-
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation. |
![]() |
In vitro biological activity of resveratrol using a novel inhalable resveratrol spray-dried formulation. |
![]() |
In vitro cell integrated impactor deposition methodology for the study of aerodynamically relevant size fractions from commercial pressurised metered dose inhalers |
![]() |
Inhalation drug delivery : techniques and products |
![]() ![]() ![]() ![]() ![]() |
Investigation into physical–chemical variables affecting the manufacture and dissolution of wet-milled clarithromycin nanoparticles |
![]() |
Investigation into the influence of polymeric stabilizing excipients on inter-particulate forces in pressurised metered dose inhalers. |
![]() |
Investigation into the Manufacture and Properties of Inhalable High-Dose Dry Powders Produced by Comilling API and Lactose with Magnesium Stearate |
![]() |
Is the cellular uptake of respiratory aerosols delivered from different devices equivalent? |
![]() |
Is there a role for inhaled anti-inflammatory drugs in cystic fibrosis treatment? |
![]() |
Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems |
![]() |
Knowledge that people with intellectual disabilities have of their inhaled asthma medications: messages for pharmacists |
![]() |
Lactose composite carriers for respiratory delivery |
![]() |
Limitations of high dose carrier based formulations. |
![]() |
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia |
![]() |
Magnetised Thermo Responsive Lipid Vehicles for Targeted and Controlled Lung Drug Delivery |
![]() |
Mannitol delivery by vibrating mesh nebulisation for enhancing mucociliary clearance |
![]() |
Measuring charge and mass distributions in dry powder inhalers using the electrical Next Generation Impactor (eNGI). |
![]() |
Micro-particle corrugation, adhesion and inhalation aerosol efficiency |
![]() |
Microfluidic production of endoskeleton droplets with controlled size and shape |
![]() |
Micronized drug powders in binary mixtures and the effect of physical properties on aerosolization from combination drug dry powder inhalers |
![]() |
Microstructural analysis of porous composite materials: dynamic imaging of drug dissolution and diffusion through porous matrices |
![]() |
Modelling of molecular phase transitions in pharmaceutical inhalation compounds: An in silico approach |
![]() |
Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles |
![]() |
Mono- and Cocultures of Bronchial and Alveolar Epithelial Cells Respond Differently to Proinflammatory Stimuli and Their Modulation by Salbutamol and Budesonide |
![]() |
Multi-breath dry powder inhaler for delivery of cohesive powders in the treatment of bronchiectasis. |
![]() |
Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies. |
![]() |
Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder |
![]() |
Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages |
![]() |
The nanoscale in pulmonary delivery. Part 2: formulation platforms |
![]() |
Nanotoxicologic Effects of PLGA Nanoparticles Formulated with a Cell-Penetrating Peptide: Searching for a Safe pDNA Delivery System for the Lungs |
![]() |
Nasal Powder Formulation of Tranexamic Acid and Hyaluronic Acid for the Treatment of Epistaxis |
![]() |
A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics |
![]() |
A novel high-speed imaging technique to predict the macroscopic spray characteristics of solution based pressurised metered dose inhalers. |
![]() |
Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery. |
![]() |
Novel simvastatin inhalation formulation and characterisation |
![]() |
Overcoming dose limitations using the orbital |
![]() |
Paclitaxel-eluting silicone airway stent for preventing granulation tissue growth and lung cancer relapse in central airway pathologies |
![]() |
Particle aerosolisation and break-up in dry powder inhalers: evaluation and modelling of the influence of grid structures for agglomerated systems |
![]() |
Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: An AFM and Raman investigation |
![]() |
Pharmaceutical applications of the Calu-3 lung epithelia cell line. |
![]() |
Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines |
![]() |
Polymer coating of carrier excipients modify aerosol performance of adhered drugs used in dry powder inhalation therapy |
![]() |
The potential to treat lung cancer via inhalation of repurposed drugs |
![]() |
Preparation and Evaluation of Single and Co-Engineered Combination Inhalation Carrier Formulations for the Treatment of Asthma |
![]() |
Primary Air-Liquid Interface Culture of Nasal Epithelium for Nasal Drug Delivery. |
![]() |
Pulmonary spray dried powders of tobramycin containing sodium stearate to improve aerosolization efficiency |
![]() |
Real-time quantitative monitoring of <i>in vitro</i> nasal drug delivery by a nasal epithelial mucosa-on-a-chip model |
![]() |
Recent advances in controlled release pulmonary therapy |
![]() |
Recent advances in curcumin nanoformulation for cancer therapy |
![]() |
Recent advances in understanding the influence of composite-formulation properties on the performance of dry powder inhalers |
![]() |
Respiratory medication use in an Australian developmental disability clinic population: messages for health care professionals |
![]() |
Revealing pMDI Spray Initial Conditions: Flashing, Atomisation and the Effect of Ethanol. |
![]() |
A review of co-milling techniques for the production of high dose dry powder inhaler formulation |
![]() |
A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection |
![]() |
Role of agglomeration in the dispersion of salmeterol xinafoate from mixtures for inhalation with differing drug to fine lactose ratios |
![]() |
Salbutamol sulfate absorption across Calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs |
![]() |
Scanning white-light interferometry as a novel technique to quantify the surface roughness of micron-sized particles for inhalation |
![]() |
Smart thermosensitive chitosan hydrogel for nasal delivery of ibuprofen to treat neurological disorders |
![]() |
Solid lipid budesonide microparticles for controlled release inhalation therapy |
![]() |
Solid lipid microparticles as an approach to drug delivery |
![]() |
The solid-state and morphological characteristics of particles generated from solution-based metered dose inhalers: Influence of ethanol concentration and intrinsic drug properties |
![]() |
Strategies to Enhance Drug Absorption via Nasal and Pulmonary Routes |
![]() |
Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection. |
![]() |
Synthesis and Characterization of Inhalable Flavonoid Nanoparticle for Lung Cancer Cell Targeting. |
![]() |
Temporally and Spatially Resolved x-ray Fluorescence Measurements of in-situ Drug Concentration in Metered-Dose Inhaler Sprays |
![]() |
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model |
![]() |
Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro. |
![]() |
Tuning aerosol performance using the multibreath Orbital® dry powder inhaler device: controlling delivery parameters and aerosol performance via modification of puck orifice geometry. |
![]() |
Under pressure: predicting pressurized metered dose inhaler interactions using the atomic force microscope |
![]() |
An update on the use of rifapentine for tuberculosis therapy |
![]() |
The Use of AFM and Surface Energy Measurements to Investigate Drug-Canister Material Interactions in a Model Pressurized Metered Dose Inhaler Formulation |
![]() |
The use of atomic force microscopy to study the conditioning of micronised budesonide |
![]() |
The use of computational approaches in inhaler development |
![]() |
The use of fatty acids as absorption enhancer for pulmonary drug delivery. |
![]() |
The use of inverse gas chromatography for the study of lactose and pharmaceutical materials used in dry powder inhalers. |
![]() |
The Use of Organic Vapor Sorption to Determine Low Levels of Amorphous Content in Processed Pharmaceutical Powders |
![]() |
Using individualized three-dimensional printed airway models to guide airway stent implantation |
![]() |
The utility of 3D-printed airway stents to improve treatment strategies for central airway obstructions |
![]() |